--- title: "Meta Platforms | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 60.8 B" type: "News" locale: "en" url: "https://longbridge.com/en/news/294252633.md" datetime: "2026-07-29T20:05:27.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294252633.md) - [en](https://longbridge.com/en/news/294252633.md) - [zh-HK](https://longbridge.com/zh-HK/news/294252633.md) generator: "portal-rs" --- # Meta Platforms | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 60.8 B Revenue: As of FY2026 Q2, the actual value is USD 60.8 B, beating the estimate of USD 60.29 B. EPS: As of FY2026 Q2, the actual value is USD 6.18, missing the estimate of USD 7.2214. EBIT: As of FY2026 Q2, the actual value is USD 18.78 B. The provided reference, a Form 8-K filing by Meta Platforms, Inc., states that it does not contain specific financial or operational metrics, segment revenues, cash flow data, or unique company-specific indicators. It refers to Exhibit 99.1, the press release dated July 29, 2026, as the source for these details and any reconciliation of GAAP to non-GAAP results. Therefore, no financial metrics or outlook information can be extracted directly from the provided text. ### Related Stocks - [META.US](https://longbridge.com/en/quote/META.US.md) ## Related News & Research - [OpenAI CFO Sarah Friar says ChatGPT's ads should be like 'if Google and Meta had a baby'](https://longbridge.com/en/news/298353501.md) - [Wall Street keeps asking how much Meta will spend. The better question is at what price to buy](https://longbridge.com/en/news/298332183.md) - [Meta Chief Accounting Officer Aaron Anderson disposes of 3,240 shares for $2 million](https://longbridge.com/en/news/298370477.md) - [Developers get 21x cheaper Muse Spark access if they let Meta train on their prompts](https://longbridge.com/en/news/297960240.md) - [Meta partners with Virtuix to bring Omni One VR treadmill to Quest ecosystem](https://longbridge.com/en/news/298192915.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**